Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.700 $1.03 Friday, 10th May 2024 HOOK stock ended at $0.768. This is 4.00% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.46% from a day low at $0.740 to a day high of $0.81.
90 days $0.605 $1.03
52 weeks $0.410 $2.05

Historical Hookipa Pharma Inc. prices

Date Open High Low Close Volume
Aug 30, 2023 $0.682 $0.740 $0.665 $0.672 325 579
Aug 29, 2023 $0.680 $0.700 $0.676 $0.687 162 029
Aug 28, 2023 $0.709 $0.709 $0.676 $0.690 135 370
Aug 25, 2023 $0.706 $0.706 $0.678 $0.687 211 290
Aug 24, 2023 $0.680 $0.710 $0.680 $0.703 175 498
Aug 23, 2023 $0.681 $0.720 $0.681 $0.714 241 283
Aug 22, 2023 $0.730 $0.730 $0.620 $0.690 247 676
Aug 21, 2023 $0.711 $0.730 $0.690 $0.725 106 510
Aug 18, 2023 $0.730 $0.740 $0.690 $0.697 153 000
Aug 17, 2023 $0.720 $0.722 $0.690 $0.722 243 956
Aug 16, 2023 $0.720 $0.732 $0.696 $0.714 399 265
Aug 15, 2023 $0.710 $0.730 $0.700 $0.730 261 300
Aug 14, 2023 $0.721 $0.738 $0.711 $0.720 1 348 302
Aug 11, 2023 $0.751 $0.751 $0.721 $0.730 223 118
Aug 10, 2023 $0.720 $0.760 $0.714 $0.745 365 988
Aug 09, 2023 $0.730 $0.750 $0.714 $0.737 414 388
Aug 08, 2023 $0.739 $0.746 $0.722 $0.728 160 481
Aug 07, 2023 $0.775 $0.775 $0.720 $0.730 397 729
Aug 04, 2023 $0.760 $0.790 $0.741 $0.765 309 155
Aug 03, 2023 $0.751 $0.768 $0.738 $0.756 341 409
Aug 02, 2023 $0.780 $0.780 $0.740 $0.770 420 646
Aug 01, 2023 $0.80 $0.81 $0.770 $0.786 629 703
Jul 31, 2023 $0.768 $0.800 $0.760 $0.790 209 934
Jul 28, 2023 $0.740 $0.773 $0.722 $0.767 363 371
Jul 27, 2023 $0.787 $0.787 $0.722 $0.735 603 493
Click to get the best stock tips daily for free!

About Hookipa Pharma Inc.

Hookipa Pharma. HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-2... HOOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT